ROBYN THIRKILL: Open Payments
NPI 1467144907 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 62 payments from 20 companies in 2025. Trend: 2023 $534 · 2024 $1,388 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $398 |
| PFIZER INC. | 10 | $195 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $167 |
| Novo Nordisk Inc | 6 | $118 |
| Dexcom, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Boston Scientific Corporation | 1 | $57 |
| Gilead Sciences, Inc. | 2 | $48 |
| Amgen Inc. | 3 | $42 |
| Organon LLC | 2 | $40 |
Products named: VRAYLAR, Kerendia, NURTEC ODT, QULIPTA, UBRELVY, Dexcom G6 Transmitter, CAPLYTA, General - Pain Management.
Industry payments across VA — which companies pay providers there.
